BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27579742)

  • 1. Serum lipid profile and clinical characteristics of patients with xanthelasma palpebrarum.
    Kavoussi H; Ebrahimi A; Rezaei M; Ramezani M; Najafi B; Kavoussi R
    An Bras Dermatol; 2016; 91(4):468-71. PubMed ID: 27579742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral extensive xanthelasma palpebrarum.
    Tosti A; Varotti C; Tosti G; Giovannini A
    Cutis; 1988 Feb; 41(2):113-4. PubMed ID: 3345685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xanthelasma palpebrarum treatment with a 1,450-nm-diode laser.
    Park EJ; Youn SH; Cho EB; Lee GS; Hann SK; Kim KH; Kim KJ
    Dermatol Surg; 2011 Jun; 37(6):791-6. PubMed ID: 21605240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of xanthelasma palpebrarum by 1064-nm Q-switched Nd:YAG laser: a study of 11 cases.
    Fusade T
    Br J Dermatol; 2008 Jan; 158(1):84-7. PubMed ID: 17916214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xanthelasma: clinical indicator of decreased levels of high-density lipoprotein cholesterol.
    Bates MC; Warren SG
    South Med J; 1989 May; 82(5):570-4. PubMed ID: 2717981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Xanthelasma and juvenile xanthogranuloma in a 7-year-old boy].
    Le Bidre E; Delage M; Lejars O; Machet MC; Lorette G; Maruani A
    Ann Dermatol Venereol; 2009 Oct; 136(10):723-6. PubMed ID: 19801258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposite effects on serum cholesteryl ester transfer protein levels between long-term treatments with pravastatin and probucol in patients with primary hypercholesterolemia and xanthoma.
    Inazu A; Koizumi J; Kajinami K; Kiyohar T; Chichibu K; Mabuchi H
    Atherosclerosis; 1999 Aug; 145(2):405-13. PubMed ID: 10488970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xanthelasma palpebrarum and its relation to atherosclerotic risk factors and lipoprotein (a).
    Ozdöl S; Sahin S; Tokgözoğlu L
    Int J Dermatol; 2008 Aug; 47(8):785-9. PubMed ID: 18717856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Xanthelasma palpebrarum and dyslipoproteinaemia: two retrospective studies (author's transl)].
    Rouffy J; Chanu B; Bakir R; Goy-Loeper J; Bouthillier D; Goussault Y; Dreux C
    Ann Dermatol Venereol; 1982; 109(3):231-5. PubMed ID: 7114736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pathogenesis and clinical significance of xanthelasma palpebrarum.
    Bergman R
    J Am Acad Dermatol; 1994 Feb; 30(2 Pt 1):236-42. PubMed ID: 8288783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xanthelasma palpebrum--a marker for hyperlipidemia in NIDDM patients?
    Premalatha G; Mohan V
    J Assoc Physicians India; 1996 Jan; 44(1):73-4. PubMed ID: 8773112
    [No Abstract]   [Full Text] [Related]  

  • 12. Dyslipidemia and its association with meibomian gland dysfunction.
    Braich PS; Howard MK; Singh JS
    Int Ophthalmol; 2016 Aug; 36(4):469-76. PubMed ID: 26515235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid metabolism and apolipoprotein E phenotypes in patients with xanthelasma.
    Ribera M; Pintó X; Argimon JM; Fiol C; Pujol R; Ferrándiz C
    Am J Med; 1995 Nov; 99(5):485-90. PubMed ID: 7485205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and serum lipid profiles and LDLR genetic analysis of xanthelasma palpebrarum with nonfamilial hypercholesterolemia.
    Zhimin W; Hui W; Fengtao J; Wenjuan S; Yongrong L
    J Cosmet Dermatol; 2020 Nov; 19(11):3096-3099. PubMed ID: 32176424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The morphogenesis of Xanthelasma palpebrarum. A cytochemical investigation].
    Braun-Falco O
    Arch Klin Exp Dermatol; 1970; 238(3):292-307. PubMed ID: 4109457
    [No Abstract]   [Full Text] [Related]  

  • 16. [COMBINED THREE OPERATIONS FOR ONE STAGE DEFECTS REPAIR AFTER RESECTION OF LARGE XANTHELASMA PALPEBRARUM WITH EPICANTHUS].
    Zeng L; Chen J; Cen Y; Lei L; Qin X; Wang Y; Zeng C
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2016 Sep; 30(9):1130-1133. PubMed ID: 29786369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Xanthelasma palpebrarum].
    Kemler MA; Deenstra W; Kon M
    Ned Tijdschr Geneeskd; 1996 May; 140(19):1014-7. PubMed ID: 8684493
    [No Abstract]   [Full Text] [Related]  

  • 18. Dyslipidemia in Patients with Xanthelasma Palpebrarum Visiting the Department of Dermatology of a Tertiary Care Centre: A Descriptive Cross-sectional Study.
    Rai A; Karki S; Prasad Sah S; Narayan Kamat L; Pradhan M
    JNMA J Nepal Med Assoc; 2022 Jun; 60(250):529-532. PubMed ID: 35690977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superiorly hinged blepharoplasty flap for reconstruction of medial upper eyelid defects following excision of xanthelasma palpebrum.
    Then SY; Malhotra R
    Clin Exp Ophthalmol; 2008 Jul; 36(5):410-14. PubMed ID: 18939343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of non-HDL in managing dyslipidemia of stage 5 chronic kidney disease.
    Pennell P; Leclercq B; Delahunty MI; Walters BA
    Clin Nephrol; 2006 Nov; 66(5):336-47. PubMed ID: 17140163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.